Vivos (RDGL) Free Cash Flow (2010 - 2025)
Vivos (RDGL) reported Free Cash Flow of -$539554.0 for Q4 2025, down 14.58% on a YoY basis from -$631621.7 in Q4 2024, and down 17.68% sequentially from -$458481.0 in Q3 2025.
Vivos (RDGL) Free Cash Flow (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Free Cash Flow data on file, last reported at -$539554.0 in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 14.58% year-over-year to -$539554.0; the trailing twelve-month figure through Dec 2025 stood at -$2.1 million (down 22.19% YoY), and the FY2025 full-year result was -$2.2 million, down 28.32% from the prior year.
- Free Cash Flow retreated to -$539554.0 in Q4 2025, from -$458481.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$171119.0 in Q2 2022 to a low of -$604510.0 in Q2 2025.
- A 5-year average of -$355934.1 and a median of -$349317.0 in 2021 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 132.78% in 2021 and jumped 50.71% in 2022, its largest moves.
- Tracing RDGL's Free Cash Flow over 5 years: stood at -$235468.0 in 2021, then declined by 19.62% to -$281667.0 in 2022, then tumbled by 64.43% to -$463137.0 in 2023, then declined by 1.68% to -$470912.0 in 2024, then decreased by 14.58% to -$539554.0 in 2025.
- Business Quant data shows RDGL's Free Cash Flow at -$539554.0 in Q4 2025, -$458481.0 in Q3 2025, and -$604510.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | -21.10 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 112.00 Mn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 449.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -539,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -539,554.00 |
| Dec 31, 2025 | -539,554.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | -455,198.00 |
| Mar 31, 2025 | -455,198.00 |
| Dec 31, 2024 | -470,912.00 |
| Dec 31, 2024 | -470,912.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | -355,412.00 |
| Jun 30, 2024 | -355,412.00 |
| Mar 31, 2024 | -351,458.00 |
| Mar 31, 2024 | -351,458.00 |
| Dec 31, 2023 | -463,137.00 |
| Dec 31, 2023 | -463,137.00 |
| Sep 30, 2023 | -221,923.00 |
| Sep 30, 2023 | -221,923.00 |